| Advice You |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Management > Managing Creative People |
|
Advice You - Managing Creative People
There are a number of issues to consider when Managing Creative People: Common Characteristics / Th According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product e Creative Type Do creative people have common characteristics that we can identify, so that we ca ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in hire the right people? Some firms do not engage in creative activities because of a belief that "speci lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. al" people are needed. Many theorists and practitioners think that there are common characteristics, su here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe h as tolerance to ambiguity and risk taking. However, many others argue that there are none ("For sixte d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro en years I have been trying to find some common denominator which seems to apply to all creative people ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc There aren't any. If I could find five or six characteristics I might be more successful at hiring the easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi m. I could make a list of curiosity, vocabulary, good visual imagery etc and then I could interview hun nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically reds of people and hire the best. But I don't know of any common characteristic. We've got fifty copywr and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ iters and I suppose the good ones are judged at the end of the year, when we compare how many successfu ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi campaigns they have created"). Motivation Motivation is arguably more important than nature / ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a nurture or traits. Someone with natural ability or placed in the right environment may not take advant dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod ge of it unless motivated. There is intrinsic motivation, synergistic and non-synergistic extrinsic mot cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin ivation. How can it be induced and measured? There are many elements: material reward, progress to the tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen deal self, self-determination, self-evaluation, feedback, enjoyment, competency expansion, recognition t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel and feasibility. Learn more… The Complete MBA dissertation on Creativity Management and oth ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust r tools can be found at http://managing-cre y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products ativity.com/ You can also receive a regular, free newsletter by entering your email address at thi . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de site. Kal Bishop, MBA ********************************** You are free to reproduce this article as elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip long as no changes are made, the author's name is retained and the link to our site URL remains active tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Business Plan Outline & Checklist
|